Poland· PL-100038011
Lipanor
A ciprofibrate product containing ciprofibratum, registered in Poland by Sanofi Winthrop Industrie. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ciprofibrate is registered in 5 of 19 countries.
Countries holding a registration under ATC C10AB08 (ciprofibrate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Ciprofibrate · ATC C10AB08
5 / 19 countries
- Belgiumprice
- Franceprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Ciprofibratum
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Poland (PL)
- ATC code
- C10AB08
- ATC class
- Ciprofibrate
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990376612
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofibrate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceCIPROFIBRATE ARROW 100 mg, géluleARROW GENERIQUES
- BelgiumCiprofibrate Amdipharm 100 mgAmdipharm
- United KingdomCiprofibrate 100mg tabletsSigma Pharmaceuticals Plc
- NetherlandsModalim, tabletten 100 mgSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Липанор
- France · Ciprofibrate Arrow, Ciprofibrate Biogaran
- United Kingdom (Northern Ireland) · Ciprofibrate Accord-Uk, Ciprofibrate Zentiva
- Netherlands · Ciprofibraat Amdipharm, Modalim
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd364d08-1418-42b9-9662-443a6113d810 GET /v1/drugs/dd364d08-1418-42b9-9662-443a6113d810?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909990376612 ¦ Rp ¦ 5863\n30 kaps.",
"substance": "Ciprofibratum 100 mg",
"common_name": "Ciprofibratum",
"pl_product_id": "100038011",
"pozwolenie_nr": "03766",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ciprofibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.